Brookings Institution’s “TechTank”: Less than four percent of private investment in health R&D targets the developing world
Liz Sablich, director of communications for governance studies at Brookings, discusses findings from a report on private sector investments in overall health R&D, which found “an exceedingly small share was dedicated to the developing world,” and highlights recommendations to improve private investment in global health drugs and vaccines (4/6).